AtaiBeckley (ATAI) Depreciation and Depletion (2024 - 2026)
AtaiBeckley (ATAI) reported Depreciation and Depletion of $200000.0 for Q3 2025, little changed on a YoY basis from $200000.0 in Q3 2024, and up 100.0% sequentially from $100000.0 in Q2 2025.
AtaiBeckley (ATAI) Depreciation and Depletion (2024 - 2026) Analysis & Trends
AtaiBeckley's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- For the quarter ending Q3 2025, Depreciation and Depletion changed 0.0% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2025 stood at $500000.0 (changed N/A YoY), and the FY2024 full-year result was $200000.0, up 100.0% from the prior year.
- Depreciation and Depletion rose to $200000.0 in Q3 2025, from $100000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $100000.0 in Q1 2025 and bottomed at $100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |